According to Vericel 's latest financial reports the company's total liabilities are $0.12 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $0.12 B | 58.19% |
2022-12-31 | $80.73 M | 10.22% |
2021-12-31 | $73.24 M | 2.66% |
2020-12-31 | $71.34 M | 69.28% |
2019-12-31 | $42.14 M | 156.09% |
2018-12-31 | $16.45 M | -48.63% |
2017-12-31 | $32.03 M | 34.1% |
2016-12-31 | $23.89 M | 96.16% |
2015-12-31 | $12.17 M | 2.02% |
2014-12-31 | $11.93 M | 124.36% |
2013-12-31 | $5.32 M | -6.07% |
2012-12-31 | $5.66 M | -72.65% |
2011-12-31 | $20.71 M | -30.75% |
2010-12-31 | $29.9 M | |
2010-06-30 | $2.74 M | 37.55% |
2009-06-30 | $1.99 M | -30.91% |
2008-06-30 | $2.88 M | -37.29% |
2007-06-30 | $4.59 M | 81.06% |
2006-06-30 | $2.53 M | 192.17% |
2005-06-30 | $0.86 M | 55.73% |
2004-06-30 | $0.55 M | -3.79% |
2003-06-30 | $0.58 M | -22.67% |
2002-06-30 | $0.75 M | -25.82% |
2001-06-30 | $1.01 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Royalty Pharma RPRX | $6.29 B | 4,831.33% | ๐ฌ๐ง UK |
Neogen NEOG | $1.43 B | 1,024.72% | ๐บ๐ธ USA |